These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 16004672)

  • 1. Emerging concepts in osteoporosis and bone strength.
    Rubin CD
    Curr Med Res Opin; 2005 Jul; 21(7):1049-56. PubMed ID: 16004672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management.
    Felsenberg D; Boonen S
    Clin Ther; 2005 Jan; 27(1):1-11. PubMed ID: 15763602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Important determinants of bone strength: beyond bone mineral density.
    Friedman AW
    J Clin Rheumatol; 2006 Apr; 12(2):70-7. PubMed ID: 16601540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Osteoporosis: whom, when and how to treat?].
    Stepán J
    Cas Lek Cesk; 2009; 148(1):25-33. PubMed ID: 19634279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is bone mineral density predictive of fracture risk reduction?
    Cefalu CA
    Curr Med Res Opin; 2004 Mar; 20(3):341-9. PubMed ID: 15025843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical use of serum and urine bone markers in the management of osteoporosis.
    Srivastava AK; Vliet EL; Lewiecki EM; Maricic M; Abdelmalek A; Gluck O; Baylink DJ
    Curr Med Res Opin; 2005 Jul; 21(7):1015-26. PubMed ID: 16004668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring osteoporosis therapy: bone mineral density, bone turnover markers, or both?
    Bonnick SL; Shulman L
    Am J Med; 2006 Apr; 119(4 Suppl 1):S25-31. PubMed ID: 16563938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole bone geometry and bone quality in distal forearm fracture.
    Parkinson IH; Fazzalari NL
    J Orthop Trauma; 2008 Sep; 22(8 Suppl):S59-65. PubMed ID: 18753891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of antifracture therapies on the components of bone strength: assessment of fracture risk today and in the future.
    Davison KS; Siminoski K; Adachi JD; Hanley DA; Goltzman D; Hodsman AB; Josse R; Kaiser S; Olszynski WP; Papaioannou A; Ste-Marie LG; Kendler DL; Tenenhouse A; Brown JP
    Semin Arthritis Rheum; 2006 Aug; 36(1):10-21. PubMed ID: 16887464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is cortical bone hip? What determines cortical bone properties?
    Epstein S
    Bone; 2007 Jul; 41(1 Suppl 1):S3-8. PubMed ID: 17466615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fracture risk reduction during treatment with teriparatide is independent of pretreatment bone turnover.
    Delmas PD; Licata AA; Reginster JY; Crans GG; Chen P; Misurski DA; Wagman RB; Mitlak BH
    Bone; 2006 Aug; 39(2):237-43. PubMed ID: 16563890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical applications of bone density testing for osteoporosis.
    Lewiecki EM
    Minerva Med; 2005 Oct; 96(5):317-30. PubMed ID: 16227947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epilepsy, osteoporosis and fracture risk - a meta-analysis.
    Vestergaard P
    Acta Neurol Scand; 2005 Nov; 112(5):277-86. PubMed ID: 16218908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of high bone turnover on the biomechanical properties of the L3 vertebra in an ovine model of early stage osteoporosis.
    Kennedy OD; Brennan O; Mahony NJ; Rackard SM; O'Brien FJ; Taylor D; Lee CT
    Spine (Phila Pa 1976); 2008 Nov; 33(23):2518-23. PubMed ID: 18978592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevention and treatment of osteoporosis: a review.
    Cosman F
    MedGenMed; 2005 May; 7(2):73. PubMed ID: 16369451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technology insight: noninvasive assessment of bone strength in osteoporosis.
    Bouxsein ML
    Nat Clin Pract Rheumatol; 2008 Jun; 4(6):310-8. PubMed ID: 18431371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for osteoporosis in the adult U.S. population: ACPM position statement on preventive practice.
    Lim LS; Hoeksema LJ; Sherin K;
    Am J Prev Med; 2009 Apr; 36(4):366-75. PubMed ID: 19285200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical assessment of fracture risk and novel therapeutic strategies to combat osteoporosis.
    Nanes MS; Kallen CB
    Fertil Steril; 2009 Aug; 92(2):403-12. PubMed ID: 19559412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Increase in bone mineral density and its effect on fracture risk].
    Sone T
    Clin Calcium; 2005 Apr; 15(4):625-9. PubMed ID: 15802775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reconsidering the effects of antiresorptive therapies in reducing osteoporotic fracture.
    Chesnut CH; Rosen CJ;
    J Bone Miner Res; 2001 Dec; 16(12):2163-72. PubMed ID: 11760829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.